The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms
@article{Sindrup1990TheSS, title={The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms}, author={S. Sindrup and L. F. Gram and K. Br{\o}sen and O. Esh{\o}j and E. Mogensen}, journal={Pain}, year={1990}, volume={42}, pages={135-144} }
&NA; The effect of the selective serotonin reuptake inhibitor paroxetine on diabetic neuropathy symptoms was examined in comparison to imipramine and placebo in a randomised, double‐blind, cross‐over study. Paroxetine was given as a fixed dose of 40 mg/day, while the dose of imipramine was adjusted to yield optimal plasma levels of imipramine plus desipramine of 400–600 nM. Paroxetine significantly reduced the symptoms of neuropathy as measured by both observer‐ and self‐rating, but was… CONTINUE READING
Topics from this paper
427 Citations
The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy
- Medicine
- Clinical pharmacology and therapeutics
- 1992
- 282
Lack of effect of mianserin on the symptoms of diabetic neuropathy
- Medicine
- European Journal of Clinical Pharmacology
- 2006
- 34
Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.
- Medicine
- Drugs & aging
- 1993
- 25
Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.
- Medicine
- The New England journal of medicine
- 1992
- 843
Concentration‐response relationship in imipramine treatment of diabetic neuropathy symptoms
- Medicine
- Clinical pharmacology and therapeutics
- 1990
- 99
Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial
- Medicine
- Pain
- 1991
- 271
Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity
- Medicine
- PAIN
- 1999
- 154
Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.
- Medicine
- British journal of clinical pharmacology
- 1990
- 133
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy
- Medicine
- Pain
- 2002
- 189
Paroxetine: a review of its pharmacology, pharmacokinetics and utility in the treatment of a variety of psychiatric disorders.
- Medicine
- Expert opinion on investigational drugs
- 1999
- 22
References
SHOWING 1-10 OF 29 REFERENCES
A double-blind controlled study of a serotonin uptake inhibitor (Zimelidine) versus placebo in chronic pain patients
- Medicine
- Pain
- 1979
- 107
Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.
- Medicine
- Journal of neurology, neurosurgery, and psychiatry
- 1981
- 88
- PDF
Pain Relief in Diabetic Neuropathy: The Effectiveness of Imipramine and Related Drugs
- Medicine
- Diabetic medicine : a journal of the British Diabetic Association
- 1985
- 84
A trial of amitriptyline and fluphenazine in the treatment of painful diabetic neuropathy.
- Medicine
- JAMA
- 1986
- 52
Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.
- Medicine
- 1985
- 32
Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.
- Medicine
- The American journal of medicine
- 1985
- 10
Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study
- Medicine
- Pain
- 1985
- 149
Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood
- Medicine
- Neurology
- 1987
- 638